| Literature DB >> 33101190 |
Thomas Birkedal Stenqvist1, Monica Klungland Torstveit1, Jens Faber2, Anna Katarina Melin3.
Abstract
Cyclists often apply block periodization to high training volumes in meso- and macrocycles to optimize training adaptation and to prepare for competition. Body mass influences performance in many sports, including endurance disciplines, and conditions related to the syndrome Relative Energy Deficiency in Sports (RED-S) such as metabolic adaptations and premature osteoporosis have also been reported in male cyclists. This study aimed to determine how a 4-week mesocycle of intensified endurance training designed to increase performance, would affect markers of RED-S in well-trained male cyclists. Twenty-two participants (age: 33.5 ± 6.6 years, height: 181.4 ± 5.2 cm, weight: 76.5 ± 7.4 kg, peak oxygen uptake (VO2peak): 63.5 ± 6.6 mL·kg-1·min-1) were recruited and instructed to maintain their background training load and to follow a supervised training protocol consisting of three high-intensity interval training sessions per week with a work duration of 32 min per session. Protocols included pre- and postintervention assessment of resting metabolic rate (RMR) using a ventilated hood, body composition and bone health by dual-energy X-ray absorptiometry (DXA), blood samples, energy intake, and aerobic performance. The interval training increased participants' aerobic performance-peak power output [4.8%, p < 0.001], VO2peak [2.4%, p = 0.005], and functional threshold power [6.5%, p < 0.001] as well as total testosterone levels [8.1%, p = 0.011]-while no changes were observed in free testosterone [4.1%, p = 0.326]. Bodyweight, body composition, and energy intake were unchanged from pre- to post-test. Triiodothyronine (T3) [4.8%, p = 0.008], absolute RMR [3.0%, p = 0.010], relative RMR [2.6%, p = 0.013], and RMRratio [3.3%, p = 0.011] decreased, and cortisol levels increased [12.9%, p = 0.021], while no change were observed in the total testosterone:cortisol ratio [1.6%, p = 0.789] or the free testosterone:cortisol (fT:cor) ratio [3.2%, p = 0.556]. A subgroup analysis of the five participants with the largest increase in fT:cor ratio, revealed a greater improvement in functional threshold power (9.5 vs. 2.5%, p = 0.037), and higher relative RMR (0.6 vs. -4.2% p = 0.039, respectively). In conclusion, 4 weeks of intensified endurance interval training increased the athletes' aerobic performance and testosterone levels. However, negative changes in markers related to RED-S, such as a reduction in RMR and T3, and an increase in cortisol were observed. These results indicate the complexity involved, and that male athletes are at risk of developing clinical indications of RED-S even during a short 4-week endurance training mesocycle.Entities:
Keywords: endurance athletes; energy availability; hormonal response; male cyclists; resting metabolic rate; testosterone; training intervention
Mesh:
Substances:
Year: 2020 PMID: 33101190 PMCID: PMC7545350 DOI: 10.3389/fendo.2020.512365
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1Participation flow. The study was conducted in Kristiansand, Norway.
Figure 2Schematic overview of study design. Pre- and posttest measures included rested and fasted resting metabolic rate (RMR), dual-energy X-ray absorptiometry (DXA), and blood sampling. An incremental exercise test for determination of peak oxygen uptake (VO2peak) and peak power output (PPO) as well as a 40-min functional threshold power-test (FTP) were performed in an unfasted state. Diet registration were performed during four consecutive days.
Descriptive characteristics of athletes included in the final analysis.
| Age (years) | 33.3 ± 6.7 |
| Height (cm) | 180.8 ± 4.9 |
| Weight (kg) | 75.8 ± 7.3 |
| BMI (kg/m2) | 23.2 ± 1.9 |
| Body fat (kg) | 11.1 ± 4.5 |
| Body fat (%) | 14.9 ± 5.2 |
| FFM (kg) | 65.5 ± 5.2 |
| Resting HR (beats/minute) | 48.0 ± 8.0 |
| VO2peak (mL.kg−1.minute−1) | 63.5 ± 6.6 |
| VO2peak (L.minute−1) | 4.8 ± 0.4 |
| Exercise (h/year) | 395 ± 171 |
| Active within cycling (years) | 12.9 ± 9.7 |
Data are presented as mean ± SD.
measured by DXA. BMI, body mass index; DXA, dual-energy X-ray absorptiometry; FFM, fat-free mass; HR, heart rate; VO.
Aerobic performance variables at pre- and posttest. Results from paired-sample t-tests (post-pre).
| PPO (Watt) | 397 | 416 | 18.5 ± 12.4 | 12.7–24.3 | <0.001 | 4.8 | 1.49 |
| VO2peak (mL.kg−1.minute−1) | 63.5 | 65.0 | 1.5 ± 2.1 | 0.5–2.5 | 0.005 | 2.4 | 0.72 |
| VO2peak (L.minute−1) | 4.8 | 4.9 | 0.1 ± 0.2 | 0.01–0.2 | 0.026 | 2.1 | 0.54 |
| FTP (Watt) | 261 | 278 | 17.0 ± 11.8 | 11.5–22.5 | <0.001 | 6.5 | 1.44 |
| FTP (Watt/kg) | 3.5 | 3.7 | 0.2 ± 0.2 | 0.2–0.3 | <0.001 | 6.9 | 1.48 |
Data are presented as mean ± SD of difference, 95% CI, percent change from pre to posttest and effect size (Cohen's D). PPO, aerobic peak power output; VO.
RMR, energy intake, macronutrients, and body composition at pre- and posttest. Results from paired-sample t-tests (post-pre).
| Absolute RMR (kcal·day−1) | 1,768 | 1,716 | −52 ± 81 | −90.3 to −14.1 | 0.010 | −3.0 | 0.64 |
| Relative RMR (kcal·kg−1 FFM·day−1) | 26.9 | 26.2 | −0.8 ± 1.2 | −1.3 to −0.2 | 0.013 | −2.6 | 0.67 |
| RMRratio | 0.91 | 0.88 | −0.03 ± 0.04 | −0.1 to 0.0 | 0.011 | −3.3 | 0.75 |
| Energy intake (kcal) | 3,015 | 3,021 | 5.6 ± 560.6 | −256.7 to 268.0 | 0.965 | 0.2 | 0.01 |
| Carbohydrate intake (g) | 332 | 338 | 5.2 ± 74.2 | −30.6 to 40.9 | 0.766 | 1.8 | 0.07 |
| Relative carbohydrate intake (g/kg) | 4.4 | 4.5 | 0.1 ± 1.1 | −0.4 to 0.6 | 0.607 | 2.2 | 0.09 |
| Protein intake (g) | 124 | 128 | 4.7 ± 25.0 | −7.4 to 16.7 | 0.428 | 3.2 | 0.19 |
| Relative protein intake (g/kg) | 1.6 | 1.7 | 0.07 ± 0.4 | −0.1 to 0.2 | 0.388 | 6.3 | 0.17 |
| Fat intake (g) | 123 | 125 | 1.7 ± 29.8 | −12.6 to 16.1 | 0.803 | 1.6 | 0.06 |
| Relative fat intake (g/kg) | 1.6 | 1.7 | 0.03 ± 0.5 | −0.2 to 0.2 | 0.741 | 1.8 | 0.06 |
| Body weight (kg) | 75.8 | 75.7 | −0.16 ± 0.7 | −0.5 to 0.2 | 0.342 | −0.1 | 0.23 |
| FFM (kg) | 65.5 | 65.5 | −0.05 ± 0.8 | −0.4 to 0.3 | 0.764 | 0.0 | 0.06 |
| Fat mass (kg) | 11.1 | 11.0 | −0.09 ± 0.7 | −0.4 to 0.2 | 0.563 | −0.9 | 0.13 |
Data are presented as mean ± SD of difference, 95% CI, percent change from pre- to post-test and effect size (Cohen's D).
measured by DXA. DXA, dual-energy X-ray absorptiometry; FFM, fat-free mass; RMR, resting metabolic rate.
Blood markers at pre- and posttest. Results from paired-sample t-tests (post-pre).
| Total testosterone (nmol/L) | 17.4 | 18.8 | 1.35 ± 2.13 | 0.35–2.35 | 0.011 | 8.1 | 0.63 |
| Free testosterone (nmol/L) | 0.459 | 0.478 | 0.020 ± 0.087 | −0.021 to 0.060 | 0.326 | 4.1 | 0.23 |
| Cortisol (nmol/L) | 381.1 | 430.3 | 49.25 ± 87.31 | 8.39–90.11 | 0.021 | 12.9 | 0.56 |
| Free testosterone:cortisol ratio | 0.00125 | 0.00121 | 0.0001 ± 0.0003 | −0.0001 to 0.0001 | 0.556 | −3.2 | 0.06 |
| Total testosterone:cortisol ratio | 0.047 | 0.046 | 0.001 ± 0.012 | −0.007 to 0.005 | 0.789 | 1.6 | 0.06 |
| SHBG (nmol/L) | 39.7 | 40.2 | 0.45 ± 4.23 | −1.53 to 2.43 | 0.640 | 2.8 | 0.11 |
| T3 (nmol/L) | 2.1 | 2.0 | −0.12 ± 0.18 | −0.02 to −0.04 | 0.008 | −4.8 | 0.67 |
| Insulin (pmol/L) | 34.7 | 31.0 | −3.70 ± 10.20 | −8.48 to 1.08 | 0.121 | −10.6 | 0.36 |
| IGF-1(nmol/L) | 18.1 | 18.0 | −0.16 ± 2.06 | −1.12 to 0.81 | 0.740 | −0.6 | 0.08 |
Data are presented as mean ± SD of difference, 95% CI, percent change from pre to post-test and effect size (Cohen's D). [xx-xx] indicates reference values. IGF-1, insulin-like growth factor-1; SHBG, sex hormone-binding globulin; T.
Relative changes in hormonal and performance variables from pre- to post-test in participants with highest increase vs. highest decrease in free testosterone:cortisol ratio. Results from independent sample t-test.
| Total testosterone | 18.7 ± 20.6 | −4.1 ± 8.9 | 0.053 |
| Free testosterone | 24.7 ± 26.0 | −7.8 ± 9.0 | 0.030 |
| Cortisol | −6.9 ± 17.7 | 32.3 ± 15.5 | 0.006 |
| SHBG | −4.1 ± 6.1 | 4.2 ± 7.4 | 0.088 |
| T3 | −10.0 ± 3.5 | −11.0 ± 7.4 | 0.803 |
| Insulin | −8.1 ± 17.6 | −1.3 ± 30.0 | 0.675 |
| IGF-1 | −7.2 ± 3.0 | −3.9 ± 6.8 | 0.352 |
| PPO | 6.3 ± 4.1 | 4.2 ± 3.2 | 0.388 |
| VO2peak | 3.8 ± 3.8 | 2.4 ± 3.8 | 0.557 |
| FTP | 9.5 ± 5.4 | 2.5 ± 3.1 | 0.037 |
| Training volume (h/week) | −5.1 ± 31.5 | 2.7 ± 18.9 | 0.650 |
| Energy intake | 6.6 ± 22.6 | 10.2 ± 38.2 | 0.860 |
| Relative RMR | 0.6 ± 2.8 | −4.2 ± 3.3 | 0.039 |
| Body weight | −0.4 ± 0.7 | −0.5 ± 1.2 | 0.901 |
| FFM | −0.7 ± 1.1 | 0.3 ± 0.6 | 0.126 |
Data are presented as mean ± SD. FFM, fat free mass; FTP, functional threshold power; IGF-1, insulin like growth factor-1; PPO, peak power output; relative RMR (kcal/kg FFM/day), resting metabolic rate; SHBG, sex hormone-binding globulin; T.